Recently, we identified a genotype-by-smoking status interaction with serum leptin levels in a sample of Mexican Americans. However, it is unknown whether this phenomenon occurs in other populations as well. OBJECTIVE: The goal of this study was to examine the genetic architecture of the response to smoking in leptin levels using data from Midwestern Caucasian subjects participating in the Metabolic Risk Complications of Obesity Genes project. METHODS: We employed a variance decomposition analysis using maximum likelihood methods to model genotype-bysmoking interactions for leptin levels and examined the impact of the exclusion of smokers in a subsequent linkage analysis. RESULTS: We found significant evidence (p-value ¼ 0.027) for a genotype-by-smoking status interaction for serum leptin levels. In the subsequent linkage analysis with smokers excluded, we obtained a maximum LOD score of 3.4 (P ¼ 0.00004) near D8S1128. CONCLUSIONS: These results suggest that a QTL on chromosome 8 may have a differential effect on the expression of leptin in smokers vs nonsmokers, as first identified in Mexican Americans.
Introduction
Previous studies have demonstrated that smoking is associated with decreased body weight, [1] [2] [3] with most smokers gaining weight after cessation of smoking. [4] [5] [6] [7] Leptin, an important endophenotype of obesity, is positively correlated with adiposity. 8 Nonetheless, individuals with similar levels of adiposity may exhibit marked differences in leptin levels. 9, 10 Because of leptin's role in obesity, it was hypothesized that smoking may also influence leptin levels. 4, [11] [12] [13] Indeed, studies have demonstrated that leptin levels are lower in smokers than nonsmokers. 4, [11] [12] [13] Recent research has demonstrated a significant genotypeby-smoking status interaction with serum leptin levels in Mexican Americans.
14 Furthermore, in a genome scan of serum leptin levels in both smokers and nonsmokers, two QTLs were identified on chromosomes 2 and 8 with LOD scores of 7.5 and 2.2, respectively. 15, 16 However, when a genome scan was performed on only nonsmokers, the maximum LOD score was 3.1 on chromosome 8 in the same region (68 cM). These results suggest that a quantitative trait locus in this vicinity of chromosome 8 may have a differential effect on the expression of leptin in smokers vs nonsmokers. However, it is unknown whether this interaction is specific to the Mexican-American population, or if it exists in other populations as well. Recently, Kissebah et al 17 have published a genome scan for serum leptin levels from the Metabolic Risk Complications of Obesity Genes (MRC-OB genes) project. The highest LOD score for leptin was 5.0 on chromosome 17, but the second highest LOD score was 2.1 on chromosome 8Fap-proximately 60 cM from the region previously reported in Mexican Americans. Given the proximity of these signals on chromosome 8 in the two studies, we were interested in determining the genetic architecture of the response to smoking in leptin levels in Midwestern Caucasian subjects participating in the MRC-OB genes project. Specifically, two questions were addressed: (1) Are serum leptin levels influenced by a genotype-by-smoking interaction (2) Does the linkage analyses including and excluding smokers yield similar evidence for specific QTLs influencing serum leptin levels? To address these questions, we made use of full pedigree-based variance decomposition analysis to examine differences in the contribution of both genetic and environmental factors to the expression of serum leptin levels in smokers and nonsmokers, as well as whether such interaction can be localized to a specific QTL.
Materials and methods

Subjects
The MRC-OB genes project was initiated in 1994 with the formulation of a nine-page questionnaire that collected information on family structure, health and behavior status, and detailed family and personal history of obesity and its health complications. ), availability of one parent (preferably both), as well as at least one never-obese sib and/or parent (BMIr27 kg/m 2 ) were identified and contacted for ascertainment. Families were scheduled to visit satellites (4-6 per state), where an experienced team undertook the phenotypic procedures. A more detailed questionnaire gathered personal data (date of birth, race, marital status), health history (asthma, kidney or liver disease, hypertension, heart disease, stroke, hyperlipidemia, thyroid disorders, diabetes, medications, menopausal status and hormonal replacement therapy), weight history (age of onset, maximum and minimum adult weight, dietary and exercise profiles), smoking history, as well as availability and information about family relatives (twins, sibs, adopted, fostered, stepchildren). Exclusion criteria included pregnancy, type I diabetes mellitus, history of cancer, renal or hepatic disease, severe coronary artery disease, substance abuse, corticosteroids or thyroid medications above replacement dose, and history of weight loss of more than 10% of body weight in the preceding 12 months. Research protocols were approved by the Institutional Review Board of the Medical College of Wisconsin.
A total of 2209 individuals distributed across 507 Caucasian families of predominantly northern European ancestry and residing in the Midwestern region of the United States participated in the study. Recruitment was initiated via an obese proband, with one sib who is also obese, availability of one parent (preferably both), and one never-obese sib and/or parent. Table 1 shows the pairwise relations represented by this data set.
Phenotypes
Radioimmunoassay of leptin was performed using a specific antibody to human leptin (Linco Research, Inc.). Quality controls were performed to assure stability and reliability of the assays. Five pool sera of increasing peptide concentrations were used to evaluate the intra-and interassay coefficients of variance. Serum leptin levels were available for 2077 individuals. Data were cleaned for outliers (any observations greater than 4 s.d. from the mean), reducing the sample to 2044 individuals (488 males, 1556 females), with a mean leptin level of 26.2 ng/ml and a mean BMI of 31.99 kg/m 2 . In addition, the distributions of serum leptin were checked prior to linkage analysis and showed no significant deviation from normality. Kurtosis, the distributional attribute most likely to contribute to inflation of type I error, was 0. 
Genotyping
Whole blood was obtained from all consenting family members for DNA extraction. DNA was prepared using commercial kits (Puregenet, Gentra Systems, Minneapolis MN, USA), which utilize a nonphenol-based method involving RNase A treatment. The DNA samples were stored in aliquots at 41C, and back-up DNA samples were stored in ethanol at À701C. Additional whole-blood aliquots were stored at À701C for further DNA extraction. Over 200 mg genomic DNA with a 260/280 ratio of 1.8-2.1 was available from each family member.
Genotyping was performed at the Marshfield (Wisconsin) Medical Research Foundation using the Weber screening set 20 Clear errors in the relations between individuals were ascertained, and as a result data on eight proband families were discarded. The genotypic data were also examined for Mendelian inconsistencies, and those genotypes proven to be inconsistent were also removed. The autosomal genotype data were 97.6% complete. The average ( 7 s.d.) heterozygosity of these markers used was 0.79 7 0.06, and the sex-averaged genetic spacing was 9.1 7 3.8 cM. DNA was screened using fluorescently labeled primers from Research Genetics. The PCR assay mixture contained 45 ng DNA, 0.075 mM fluorescently labeled primers, 0.12 units AmpliTaq Polymerase (Sigma Diagnostics, St Louis, MO, USA), 100 mM each dNTP, 25 mM MgCl 2 , and buffer. PCR conditions included 27 cycles of denaturation (951C for 30 s), annealing (551C for 75 s), and elongation (721C for 30 s), followed by a final 6-min elongation period. Samples were analyzed through automated high-throughput scanning fluorescence detectors (SCAFUDs), each simultaneously detecting three separate dyes.
Analytical methods
To examine the genetic architecture of the response to smoking in leptin levels, we used a two-step approach. First, we tested for the presence of genotype-by-smoking status interaction in the basic polygenic model, without linkage. Second, we compared the results from a linkage analysis of nonsmokers to the results of one including both smokers and nonsmokers. Although we would have been interested in testing for the presence of genotype-bysmoking status interaction at our QTL from the linkage analysis, this analysis requires more power than our data set currently has.
Genotype-by-smoking interactions Univariate quantitative genetic analysis was used to partition the phenotypic variance of serum leptin levels into its additive genetic and environmental variance components. This was accomplished by means of maximum likelihood variance decomposition methods 21, 22 implemented in the computer program SOLAR. 23 This approach allows for the explicit test of whether correlations among family members for a given trait are in part the result of genetic effects. A major strength of this approach is the ability to test for specific patterns of interaction such as genotype by environment (in this case genotype by smoking, G Â Sm).
The test for G Â Sm interactions is based on hypotheses concerning the nature of the variance-covariance relation of a trait between relative pairs under different environments. [24] [25] [26] The expected genetic covariance between a pair of relatives consisting of a smoker and nonsmoker is defined as
where f is the coefficient of kinship between the two individuals, r G(SM,NSM) is the genetic correlation between the expressions of the trait in the two groups, and s gSM and gNSM are the genetic standard deviations for smokers and nonsmokers, respectively (Table 2 ).
In the absence of genotype-by-smoking status interaction (ie, the null hypothesis), the genetic correlation between relatives for a trait measured in smokers and nonsmokers should be one (r G(SM,NSM) ¼ 1.0) and the genetic variances in the two groups should be equal (ie, s gSM ¼ s gNSM ). 24, 27 Conversely, if there is G Â Sm interaction, the genetic correlation between the groups (r G(SM,NSM) ) will be significantly less than 1.0 and/or the genetic variances will not be equal between the groups (s gSM as gNSM ) (Table 3) . 24, 27 Additionally, environment-by-smoking interaction (E Â Sm) would be indicated by the residual environmental variances not being equal between the groups (s eSM as eNSM ).
In this study a general model, allowing for G Â Sm interaction based on smoking status in the expression of serum leptin levels, was compared, by use of maximum likelihood procedures, to a set of three constrained (or restricted) models in which such interactions were excluded. 25, 26 The general model included 11 parameters which were estimated: male and female means, male and female age coefficients (bage), male and female age 2 coefficients (bage 2 ), )) for serum leptin levels in smokers and nonsmokers were calculated using the genotypic and environmental variance parameters estimated in the general model. The restricted models consisted of a model in which the genetic correlation between smokers and nonsmokers was constrained to 1.0, a model in which the smoker and nonsmoker genetic variances were constrained to be equal, and a model in which the smoker and nonsmoker environmental variances were constrained to be equal. Thus for all three restricted models, 10 parameters were estimated, as compared to the 11 parameters estimated in the general model.
Each of the three restricted models was compared to the general model, to test whether the restricted model fit the data significantly worse than the general model using the likelihood ratio test. When comparing models with variances constrained to be equal, interpretation of significant differences was based on the assumption of an asymptotic w 1 2 distribution for the likelihood test statistic.
However, in the case of the model that restricted the genetic correlation to one, this assumption does not hold since the genetic correlation was constrained to the upper boundary of the parameter space (r G ¼ 1.0). As a result of this constraint, the test statistic is not distributed as an asymptotic w 1
2
, but rather as a 1/2 : 1/2 mixture of a w 1 2 distribution and a point mass at zero. 28 Three inferences concerning the nature of smoking-based interactions can be made. The rejection of the model constraining the genetic correlation between the groups to equal one (ie, r G(SM,NSM) a1.0) implies that a different gene or suite of genes is contributing to the variance in leptin levels in each environment. On the other hand, rejection of the model constraining the genetic standard deviations of the groups to be equal (ie, s gSM as gNSM ) would imply that the magnitude of the genetic effect is different in the two environments. Lastly, the rejection of the model constraining the environmental standard deviations of the groups to be equal implies that something in the residual environment interacts with the smoking status.
Variance components linkage analysis To identify potential regions for genotype-by-smoking interaction, we conducted a whole-genome linkage scan excluding smokers. We compared the results of this genome scan to those obtained when including data from both smokers and nonsmokers in a previous genome scan 17 using this data set. We identified as regions of interest those locations where analyses of the data set, excluding smokers, yielded evidence for linkage that was both significant (LOD>3.0) and improved over that obtained in the previous scan including both smokers and nonsmokers. Although it is possible that genotype-byenvironment interactions could cause a reduction in LOD scores, a reduction could also be caused by reducing the sample size. Therefore, only regions of the genome in which there were increased were identified as areas of interest. A variance component model 29 applied to extended family data was used to test for evidence of linkage of QTLs for serum leptin levels with short tandem repeat (STR) loci using a 10 cM genome-wide map. We tested the null hypothesis that the additive genetic variance due to a QTL (s q 2 ) equals zero (no linkage) by comparing the likelihood of this restricted model with that of a model in which s q 2 is estimated. The difference between the two log 10 likelihoods produces a LOD score that is the equivalent of the classical LOD score of linkage analysis. Twice the difference in log e likelihoods of these models yields a test statistic that is asymptotically distributed as a 1/2 : 1/2 mixture of a w 1 2 variable and a point mass at zero. 28 This quantitative trait linkage method has been implemented in the program package SOLAR. 23 Multipoint linkage for a QTL was performed according to the methods detailed in Almasy and Blangero.
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Results
Genotype-by-smoking interaction
The mean leptin level for smokers was 20.85 7 0.88 ng/ml, while the mean level for nonsmokers was 27.74 7 0.50 ng/ml (P ¼ 0.0000041). Table 4 provides the maximum likelihood estimates for the variance component parameters for serum leptin levels in smokers and nonsmokers. The genetic standard deviations were higher in smokers than nonsmokers, while environmental standard deviations were lower in smokers than nonsmokers although these differences were not significant. The maximum likelihood estimate of the additive genetic correlation was 0.37. Based on the maximum likelihood estimates for the smoking-specific genetic and environmental standard deviations, the heritability (h 2 ) of serum leptin levels was 0.41 for smokers and 0.35 for nonsmokers. Only the model in which the genetic correlation (r G ( SM,NSM )) was constrained to one had a significantly worse fit to the data than the general model in which this parameter was estimated, indicating that different loci influence the leptin levels in smokers and nonsmokers (P ¼ 0.02656).
Linkage analysis
We detected one chromosome with LOD scores >1.9 (Figure 1) , the generally accepted level for consideration of suggestive 
Discussion
Recent research has demonstrated a significant genotype-bysmoking status interaction with serum leptin levels on chromosome 8. 14 In a genome scan of leptin in Mexican Americans, a QTL was identified on chromosome 8 with a LOD score of 2.2. 15 However, when a genome scan was performed on nonsmokers only, the LOD score on chromosome 8 increased to 3.1. 14 Moreover, these analyses yielded significant evidence for a gene-by-smoking status interaction at this QTL. However, as this study was limited to Mexican Americans, it was unclear whether this effect would be present in other populations. Interestingly, Kissebah et al 17 identified a QTL for serum leptin levels (LOD ¼ 2.1) on chromosome 8 using Midwestern Caucasians approximately 60 cM from the QTL identified in Mexican Americans. Given the proximity of these two signals, we were interested in examining whether genotype-by-smoking status interaction on serum leptin levels exists in this Caucasian population, and if a QTL in this vicinity of chromosome 8 may have a differential effect on the expression of leptin in smokers vs nonsmokers. For the genotype-by-smoking status interaction analysis, the genetic correlation between smokers and nonsmokers was significantly (P ¼ 0.02656) different from one, suggesting that a different gene or suite of genes is contributing to the variance in leptin levels in both environments. Although the genetic standard deviations were not significantly different between smokers and nonsmokers, the rejection of the genetic correlation equaling one is sufficient evidence for genotype-by-environment interactions. Indeed, the These results confirm the identification of genotype-bysmoking status interaction for serum leptin levels first identified in Mexican Americans.
14 Our genome scan of nonsmokers yielded a maximum LOD score of 3.4 (P ¼ 0.00004) on chromosome 8 at 127 cM. This LOD score is increased from 2.1 when both smokers and nonsmokers were analyzed. Although the chromosome 8 QTL was present in both genome scans, the increase in the magnitude of the LOD score when excluding smokers suggests that a genotype-by-environment interaction exists at this locus.
Interestingly, our data exhibit increased LOD scores on chromosome 8 when smokers are excluded from the analyses, as seen in the Mexican-American data set. However, the QTLs localized in these two data sets are approximately 60 cM apart, which leads to the question of whether this is a single QTL with poor localization or whether there exist two distinct QTLs. It is possible that differences in the information content of the markers as well as inflation of the marker maps could influence localization of QTLs. Given these factors, we suspect that these studies have identified the same QTL, but future studies are needed to confirm this.
In summary, this study provides evidence of a genotype-bysmoking interaction on serum leptin levels. In the genotypeby-smoking model, the genetic correlation was significantly different from one, suggesting that a different gene or suite of genes is contributing to the variance in leptin levels in smokers and nonsmokers. The hypothesis that different genes influence leptin levels in smokers and nonsmokers is further supported by our linkage analyses excluding smokers which yield different results than a previous genome scan using the full data set. Therefore, these results suggest that a QTL on chromosome 8 may have a differential effect on the expression of leptin in smokers vs nonsmokers.
